What is he best known for?
The fields of study he is best known for:
- Gene
- Immune system
- Cancer
His primary areas of study are Mesenchymal stem cell, Immunology, Immune system, Cancer research and Cell biology.
His work deals with themes such as Cell culture, Stromal cell, Clinical trial and Bone marrow, which intersect with Mesenchymal stem cell.
Jacques Galipeau combines subjects such as Progenitor cell and Transplantation with his study of Immunology.
Jacques Galipeau combines subjects such as Interferon and Cell therapy with his study of Immune system.
Jacques Galipeau interconnects Ex vivo, In vivo, Paracrine signalling, Stem cell and Innate immune system in the investigation of issues within Cancer research.
His Cell biology research incorporates elements of Molecular biology, Antigen processing, Clinical uses of mesenchymal stem cells and Fibroblast growth factor.
His most cited work include:
- Mesenchymal Stromal Cells: Clinical Challenges and Therapeutic Opportunities (502 citations)
- Allogeneic marrow stromal cells are immune rejected by MHC class I– and class II–mismatched recipient mice (452 citations)
- Human MSC suppression correlates with cytokine induction of indoleamine 2,3-dioxygenase and bystander M2 macrophage differentiation. (414 citations)
What are the main themes of his work throughout his whole career to date?
Jacques Galipeau mainly focuses on Mesenchymal stem cell, Immunology, Cancer research, Immune system and Stromal cell.
His studies in Mesenchymal stem cell integrate themes in fields like Stem cell, Cell therapy and Bone marrow.
Jacques Galipeau usually deals with Immunology and limits it to topics linked to Cytotoxic T cell and Antigen.
His Cancer research research includes elements of Adoptive cell transfer, Genetic enhancement, Paracrine signalling and In vivo.
As a part of the same scientific family, Jacques Galipeau mostly works in the field of Genetic enhancement, focusing on Molecular biology and, on occasion, Cell culture.
His work carried out in the field of Immune system brings together such families of science as Inflammation, Receptor and Indoleamine 2,3-dioxygenase.
He most often published in these fields:
- Mesenchymal stem cell (47.43%)
- Immunology (49.43%)
- Cancer research (35.14%)
What were the highlights of his more recent work (between 2016-2021)?
- Mesenchymal stem cell (47.43%)
- Cancer research (35.14%)
- Bone marrow (17.43%)
In recent papers he was focusing on the following fields of study:
Jacques Galipeau focuses on Mesenchymal stem cell, Cancer research, Bone marrow, Cell biology and Stem cell.
He has researched Mesenchymal stem cell in several fields, including Stromal cell, Paracrine signalling, Downregulation and upregulation, Immune system and Graft-versus-host disease.
His Immune system research integrates issues from Matrix and Cytokine.
His Cancer research study integrates concerns from other disciplines, such as Phenotype, Interferon gamma, B cell, Adoptive cell transfer and Peripheral blood mononuclear cell.
His Bone marrow research is classified as research in Immunology.
His work on T cell as part of his general Immunology study is frequently connected to Statement, thereby bridging the divide between different branches of science.
Between 2016 and 2021, his most popular works were:
- Mesenchymal Stromal Cells: Clinical Challenges and Therapeutic Opportunities (502 citations)
- Mesenchymal stem versus stromal cells: International Society for Cell & Gene Therapy (ISCT®) Mesenchymal Stromal Cell committee position statement on nomenclature. (111 citations)
- Potency Analysis of Mesenchymal Stromal Cells Using a Combinatorial Assay Matrix Approach (67 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Cancer
- Immune system
The scientist’s investigation covers issues in Mesenchymal stem cell, Cancer research, Clinical trial, Stem cell and Stromal cell.
His Mesenchymal stem cell study incorporates themes from Immune system, Downregulation and upregulation and Homing, Bone marrow.
His Immune system study frequently involves adjacent topics like Cytokine.
His Cancer research research is multidisciplinary, relying on both Interferon, Cancer, Internal medicine and Mechanism of action.
His biological study spans a wide range of topics, including Cell therapy, In vivo and Intensive care medicine.
His Stromal cell study combines topics from a wide range of disciplines, such as Cell and Paracrine signalling.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
